A giant renal angiomyolipoma (AML) in a patient with septo-optic dysplasia (SOD) by unknown
EUROPEAN JOURNAL 
OF MEDICAL RESEARCH
Cichocki et al. European Journal of Medical Research 2014, 19:46
http://www.eurjmedres.com/content/19/1/46CASE REPORT Open AccessA giant renal angiomyolipoma (AML) in a patient
with septo-optic dysplasia (SOD)
Marcin Cichocki*, Marek Sosnowski and Zbigniew JablonowskiAbstract
Angiomyolipoma (AML) is a rare benign renal tumor occurring in about 0.3 to 3% of the general population. Most
frequently it takes the form of small single tumors occurring sporadically or accompanying tuberous sclerosis
(Bourneville-Pringle disease). In some cases the tumor may reach a very large size and be a cause of various serious
complications. This case description concerns a 26-year-old female patient, suffering from hypopituitarism,
hypothyroidism and binocular blindness during the course of septo-optic dysplasia, in whom a giant, left renal AML
was diagnosed and treated surgically. According to the authors’ knowledge this was the first reported case of a
huge size AML in a patient with de Morsier syndrome.
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Angiomyolipoma (AML) is a rare benign renal tumor
histologically containing elements of smooth muscle,
adipose tissue and blood vessels in various proportions.
It occurs in 0.3 to 3% of the general population, four-fold
more frequently in women and the peak of incidence falls
between the 30th and 50th years of life [1]. Most fre-
quently (80%) these are small, singular tumors which
occur unilaterally and occasionally. In the remaining cases
they coexist with tuberous sclerosis (Bourneville-Pringle
disease) and they may be bilateral and multiple and
achieve significant sizes [2,3]. A tumor which is bigger
than 10 cm and affects a whole organ is considered a
‘giant’ AML [4]. Septo-optic dysplasia (de Morsier syn-
drome) is a very rare syndrome of congenital defects con-
sisting of optic nerve hypoplasia, hypopituitarism, and
agenesis of the septum pellucidum [5,6].Case presentation
The patient, a 26-year-old woman with a diagnosis of
hypopituitarism, hypothyroidism and binocular blind-
ness in the course of septo-ocular dysplasia was admit-
ted to the Clinic of Urology because of a large tumor of
the left kidney. The patient was 139 cm tall, weighed* Correspondence: chilawert@gmail.com
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unless otherwise stated.52 kg and her BMI amounted to 27 kg/m2. Her blood
pressure was 120/70 mmHg, heart rate 70/minute, cre-
atinine levels 66 μmol/l, and her electrolytes, blood
count and urinalysis were normal. The lesion had been
diagnosed incidentally in another medical centre during
investigation of persistent stomach ache with a suspicion
of pyelonephritis. During case examination a perceptible
mobile pathological resistance was reported on the left
side of the stomach from the costal arch up to the iliac
fossa. On abdominal ultrasonography (USG) examin-
ation, a large, intra-abdominal and left flank heteroge-
neous tumor with dimensions 170 × 78 mm, mostly
hyperechogenic (consisting probably of adipose tissue
with little vascularization observed in Doppler color)
and probably coming out of the left kidney, was re-
ported. The right kidney was 108 mm long, with no
urinary retention and no deposits. The diagnostics were
extended by computer tomography (CT) angiography of
the abdomen with contrast, in which the following was
stated: numerous AMLs in the left kidney, the biggest
coming out from its lower part and affecting the whole
paranephric space and going down to the level of iliac
fossa with dimensions of about 226 × 95 × 104 mm. Ex-
cept for this the other intra-abdominal organs revealed
no abnormalities (Figures 1, 2). The patient qualified for
surgical treatment. The whole kidney with the entire
tumor was removed (Figure 3 and Figure 4) by perform-
ing a median transperitoneal incision. Due to the risk ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computer tomography (CT) angiography - visible tumor and pathological vessel.
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sels. The procedure was performed without any complica-
tions with the loss of 100 ml of blood. Further recovery
proceeded without any complications. Histopathological
examination confirmed the diagnosis of AML.
Discussion
AML is one of the rarely occurring solid tumors of the
kidney (2 to 6%). Most frequently they are diagnosed byFigure 2 A different scan with a visible tumor.chance during imaging examinations and they do not
reach large sizes. They occur multifocally in about 1/3
and bilaterally in about 15% of all cases. They coexist
with tuberous sclerosis (Bourneville-Pringle disease) with
a frequency of about 20%. In such patients AML is diag-
nosed in 40 to 80% with a 2 to 3% risk of coexistence of
renal cell carcinoma (RCC). AML has a mild nature and
it does not produce metastases. Most frequently it pro-
ceeds asymptomatically. It may induce hematuria and
Figure 3 A post-surgical specimen with a visible fragment of ureter and healthy renal parenchyma.
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ous complication for health from AML is spontaneous
bleeding into the retroperitoneal space from pathological
vessels, referred to as Wünderlich syndrome [7]. Diagnosis
is based mainly on imaging examinations: USG and CT
(presence of adipose tissue within the tumor mass of
density of 10 Hounsfield units is a characteristic feature),
magnetic resonance imaging (MRI), angiography. Tumors
larger than 4 cm are usually symptomatic and these are
the tumors which require control every six months [8].
The incidence of AML larger than 10 cm in individualsFigure 4 A post-surgical specimen with a visible fragment of healthywithout a diagnosis of tuberous sclerosis is extremely rare.
The commonly applied methods of treatment include:
cryoablation, embolization, tumorectomy, partial resection
of the kidney, or nephrectomy. The choice and scope of
treatment is determined by: tumor size, its vascularization,
symptoms and comorbidities [9]. Septo-optic dysplasia (de
Morsier syndrome) is a syndrome of congenital defects
which occurs at a frequency of 1:50,000 and which con-
sists of: optic nerve hypoplasia, hypopituitarism, and agen-
esis of the septum pellucidum. Its etiology is multivariate
and still not fully known. Recent reports claim a possiblerenal parenchyma.
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opment of the pituitary and central parts of the brain.
Boys fall ill from this syndrome just as often as girls [10].
So far, an increased frequency of coexistence of renal car-
cinomas, including AML, has not been described. Herein,
we have presented the first case of a large AML in a pa-
tient with de Morsier syndrome.
Conclusions
We have presented an extremely rare case of the coexist-
ence of congenital defects in the form of septo-optic
dysplasia associated with a giant renal AML. The patient
required a precise diagnostic work-up and radical surgi-
cal treatment.
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